Growth and adrenal suppression due to moderate- to high-dose inhaled fluticasone.
Chatzimichail
A
A
Pietrobelli
A
A
Boner
A L
AL
D000309:Adrenal Insufficiency / Q000139:chemically induced*; D000730:Androstadienes / Q000009:adverse effects*; D000893:Anti-Inflammatory Agents / Q000009:adverse effects*; D001249:Asthma / Q000188:drug therapy*; D004305:Dose-Response Relationship, Drug; D000068298:Fluticasone; D006130:Growth Disorders / Q000139:chemically induced*; D006801:Humans
D000730:Androstadienes; D000893:Anti-Inflammatory Agents; D000068298:Fluticasone